MEDROXYPROGESTERONE ACETATE News

MEDROXYPROGESTERONE ACETATE currently has 8 news articles, with 19 predicted indications.

This page combines the AI-predicted indications for MEDROXYPROGESTERONE ACETATE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (19):
- endometrium neoplasm (99.0%)
- postmenopausal atrophic vaginitis (99.0%)
- endometriosis (disease) (99.0%)
- uterine corpus cancer (99.0%)
- endometrial carcinoma (disease) (99.0%)
- endometriosis of uterus (99.0%)
- postmenopausal osteoporosis (99.0%)
- endometrial cancer (99.0%)
- osteoporosis (99.0%)
- amenorrhea (disease) (100.0%)
- breast fibrocystic disease (100.0%)
- benign mammary dysplasia (99.9%)
- cervix endometriosis (99.9%)
- endometriosis of rectovaginal septum and vagina (99.9%)
- endometriosis in cutaneous scar (99.9%)
- renal hypoplasia, bilateral (99.9%)
- renal hypoplasia (disease) (99.9%)
- apocrine adenosis of breast (99.9%)
- blunt duct adenosis of breast (99.9%)